Bio

As a partner in the firm’s M&A group, Rowook Park focuses on cutting-edge technology and biotech transactions, and he has guided his clients through high-stakes public and private mergers & acquisitions, venture capital financings, and securities offerings representing an aggregate value of more than $265 billion. He’s also one of the go-to M&A advisers for complex cross-border transactions in these areas. In recent years, Ro led the Cooley team advising Horizon Therapeutics on its $28.3 billion sale to Amgen, which was the largest healthcare deal of 2022 and the third-largest all-cash healthcare deal in history as of the announcement. Ro also led the Cooley team advising Japanese payments platform Paidy on its $2.7 billion sale to PayPal, which was named M&A Deal of the Year at the International Financial Law Review’s 2022 Asia-Pacific Awards. In addition, Ro is highly sought after by boards of directors and special committees for his expertise and deep experience in activist defense, proxy contests, and corporate governance matters.